PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeywords Studios Plc Regulatory News (KWS)

Share Price Information for Keywords Studios Plc (KWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,417.00
Bid: 1,413.00
Ask: 1,420.00
Change: 17.00 (1.21%)
Spread: 7.00 (0.495%)
Open: 1,413.00
High: 1,419.00
Low: 1,378.00
Prev. Close: 1,400.00
KWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Keywords Studios (KWS): Looking like a winner as the dust settles

2 Mar 2021 07:00

Edison Investment Research Limited Keywords Studios (KWS): Looking like a winner as the dust settles 02-March-2021 / 07:00 GMT/BST


 

London, UK, 2 March 2021

 

Keywords Studios (KWS): Looking like a winner as the dust settles

Buoyed by exceptional demand for games during lockdown and boosted by the start of the console transition, the global games industry showed year-on-year growth of 20% in FY20 (Newzoo). Benefiting from increased industry development spending and the growth in new releases, Keywords delivered underlying organic revenue growth of 12%, with FY20 revenues rising 14% y-o-y. Assuming no worsening impact from COVID-19, FY21 looks set to be a more settled year. With publishers launching increasing numbers of new titles to address a growing next-gen console base in FY21-23, demand for Keywords' services should continue to build in the short to medium term. The outlook for Keywords appears positive and, with net cash of c €100m (plus €100m of undrawn facilities), Keywords remains well placed to participate in earnings-enhancing M&A.

 

Keywords' shares trade on an FY21e P/E of 38.9x, falling to 34.5x in FY22e, in line with its UK games industry peers. Although this is a demanding valuation, we expect the recent next-gen console launches to lead to a period of heightened game releases, benefiting underlying demand in the period FY21-23e. When complemented by Keywords' proven accretive buy-and-build strategy, this should further reduce valuation multiples. 

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Richard Williamson +44 (0)20 3077 5700 tech@edisongroup.com

Dan Ridsdale +44 (0)20 3077 5729 tech@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube  www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1172241 02-March-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
14th Jun 20237:00 amRNSExtension of EBT Market Purchases to EUR15 million
12th Jun 20237:16 amRNSIssue of Shares
9th Jun 20237:00 amRNSDirector Share Purchase
8th Jun 20232:42 pmRNSHolding(s) in Company
1st Jun 20233:53 pmRNSTotal Voting Rights
26th May 20232:55 pmRNSResult of AGM
24th May 20234:06 pmRNSDirector/PDMR Shareholding
23rd May 20233:34 pmRNSIssue of Shares
23rd May 20231:45 pmRNSHolding(s) in Company
22nd May 20234:10 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSBlock listing return
15th May 20237:00 amRNSPassing of Ross Graham and Chairman Succession
11th May 20234:45 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAcquisition
9th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 20234:49 pmRNSTotal Voting Rights
18th Apr 20239:46 amRNSBlock Admission
17th Apr 20237:00 amRNSPublication of Annual Report and Accounts
3rd Apr 20239:59 amRNSTotal Voting Rights
3rd Apr 20238:56 amRNSIssue of Shares
31st Mar 202312:11 pmRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAcquisition
15th Mar 20237:00 amRNSFinal Results
9th Mar 20233:32 pmRNSIssue of Shares
1st Mar 20234:56 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSTotal Voting Rights
13th Feb 20231:38 pmRNSIssue of Shares
1st Feb 20237:01 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSAcquisition
25th Jan 20237:00 amRNSFull Year Trading Update
19th Jan 20237:00 amRNSDirectorate Change
16th Jan 20232:16 pmRNSHolding(s) in Company
12th Jan 202312:17 pmRNSIssue of Shares
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20229:00 amRNSAcquisition
13th Dec 20227:00 amRNSAcquisition
9th Dec 20225:02 pmRNSDirector/PDMR Shareholding
8th Dec 20224:52 pmRNSDirector/PDMR Shareholding
7th Dec 202210:57 amRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition
1st Dec 20227:00 amRNSTotal Voting Rights
21st Nov 20223:00 pmRNSIssue of Shares
21st Nov 20227:00 amRNSTrading Update
14th Nov 20227:00 amRNSBlock Listing Return
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20222:30 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSAppointment of Chief Operating Officer Designate
21st Oct 20227:00 amRNSBlock Admission
19th Oct 20227:00 amRNSIssue of Shares
6th Oct 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.